ResMed Inc.
US ˙ NYSE ˙ US7611521078

SecurityRMD / ResMed Inc.
InstitutionSlateStone Wealth, LLC
Latest Disclosed Ownership16,384 shares
Latest Disclosed Value $ 3,678
SlateStone Wealth, LLC reports 8.64% increase in ownership of RMD / ResMed Inc.

On May 14, 2026 - SlateStone Wealth, LLC filed a 13F-HR form disclosing ownership of 16,384 shares of ResMed Inc. (US:RMD) valued at $3,677,880 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 15,081 shares of ResMed Inc.. This represents a change in shares of 8.64% during the quarter. The current value of the position is $3,054,961 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ResMed COM 761152107 16,384 1,303 8.64 4 0.00 0.3032
2026-02-11 2025-12-31 13F ResMed COM 761152107 15,081 -19 -0.13 4 -25.00 0.3039
2025-11-05 2025-09-30 13F ResMed COM 761152107 15,100 1,008 7.15 4 33.33 0.3578
2025-08-12 2025-06-30 13F ResMed COM 761152107 14,092 869 6.57 4 50.00 0.3400
2025-05-08 2025-03-31 13F ResMed COM 761152107 13,223 977 7.98 3 0.00 0.2971
2025-02-10 2024-12-31 13F ResMed COM 761152107 12,246 696 6.03 3 0.00 0.2747
2024-11-07 2024-09-30 13F ResMed COM 761152107 11,550 1,152 11.08 3 100.00 0.2539
2024-07-25 2024-06-30 13F ResMed COM 761152107 10,398 1,112 11.98 2 0.00 0.2156
2024-04-26 2024-03-31 13F ResMed COM 761152107 9,286 1,108 13.55 2 0.00 0.1847
2024-02-01 2023-12-31 13F ResMed COM 761152107 8,178 -910 -10.01 1 0.00 0.1826
2023-10-12 2023-09-30 13F ResMed COM 761152107 9,088 876 10.67 1 0.00 0.1955
2023-08-07 2023-06-30 13F ResMed COM 761152107 8,212 118 1.46 2 0.00 0.3361
2023-08-08 2023-03-31 13F ResMed COM 761152107 8,094 1,559 23.86 2 -99.93 0.3672
2023-02-01 2022-12-31 13F ResMed COM 761152107 6,535 1,101 20.26 1,360 14.67 0.3281
2022-11-03 2022-09-30 13F ResMed COM 761152107 5,434 5,434 1,186 0.3156
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.